Name
: Ahmed Abd El-Bary Abd El-Rahman
Born
: August 15, 1938, Sohag, Egypt
Address
: Home:
17, Ghazza Street, El-Mohandesseen, Guiza, Egypt
Tel. No. 346 23 39
Office:
Faculty of Pharmacy,
Kasr El-Aini Street
Cairo, Egypt
Tel. No.3628426
Fax: + 202 362 5865
Marital Status: Married, Have 3 Children
Qualifications: - B. Pharm., Faculty of Pharmacy, Cairo University,
1962.
- M. Pharm., Faculty of Pharmacy, Cairo University, 1967.
- Ph. D. Pharmaceutics, Faculty of Pharmacy, Cairo University, 1970.
- Post Doctoral Associate in School of Pharmacy, University of Georgia,
USA, 1979 - 1981.
- Present Occupation: Professor of Pharmaceutics, and Direction of
Center of Applied Research and Advanced Studies, Faculty of
Pharmacy, Cairo University.
- Post Graduate Activities: Dean, Faculty of Pharmacy, Cairo University
1993 - 1998
- Vice Dean for Education and Students Affairs, Faculty of Pharmacy,
Cairo University, 1987 - 1993.
- Department of Pharmaceutics, Faculty of Pharmacy, Cairo University:
- Professor since 1980
- Associate Professor 1975 - 1980.
- Assistant Professor 1970 - 1975.
1
- Instructor 1964 - 1970.
Current University Affiliations With Titles:
Teaching and supervising a course in pharmaceutics to both
undergraduate and postgraduate students at the Faculty of Pharmacy:
- Cairo University.
- Mansourah University.
- Assiut University.
- Zagazig University.
* Supervisor on Ph. D. and M. Pharm. Thesis.
* Research consultant, C.I.D. Pharmaceutical Company and El- Nasr
Pharmaceutical Company and others.
* Consultant for NODCAR (National Organization for Drug Research
and Control).
* Leading a training program for continuous education for pharmacists.
* Leading a training program for hospital pharmacists in Egypt.
* Leader for more than 60 bioequivalence studies.
Honours and Professional Societies/Associations/Affiliations:
* Egyptian Pharmaceutical Syndicate.
* Head of the Egyptian Pharmaceutical Society since 1992.
* Head of the Egyptian Society of Hospital Pharmacy.
* Head of the Committee of the Egyptian Pharmacopoeia since 1997.
* Head of the Committee of the Arab Pharmacopoeia.
* Member the Arabian Union of Pharmacists.
* Staff Members Club of Cairo University.
* Cairo Egyptian Pharmaceutical Syndicate.
* Member of Board of Club of Pharmacists.
2
* Granted National Prize on Medical Science in 1984.
* Granted the Egyptian Republic Order of Sciences and Art First Level in
1985.
* Head of the Arab Academy of Science since 1992.
* Editor, Egyptian Journal of Pharmaceutical Science.
* Member of the Board of NODCAR.
* Member of New York, Academy of Science USA.
* Member of the Committee of drug registration, Ministry of health and
population.
Scientific Books:
Biopharmaceutics and Pharmacokinetic.
Guidelines for Good Hospital Practics.
Guielines for Good Storage Practice.
Egyptian Hospital Formulary.
Guidelines for Good Pharmacy Practice of Pharmaceuticals In Egypt.
Guidelines for Handling of Cytotoxic Drugs.
Guidelines for Quality Control of Cosmetics.
Publications:
1.Technological Formulation of a Stable Paracetamol Phenobarbital
Suppository; Bull. Fac. Pharm., Cairo University, Vol. X No. 1, 131
(1971).
2. Stability of Fluid Extract of Liquorice; Bull. Fac. Pharm., Cairo
University, Vol. XI, No. 1, 219 (1972).
3. Formulation and Stabilization of Phenylbutazone Sodium Injectable
Solution; Bull. Fac. Cairo University, Vol. XI No. 1, 161 (1972).
4. Stability of Phenylbutazone in Ointments; Bull. Fac. Pharm., Cairo
University, Vol. XI, No. 1, 189 (1972).
3
5. Technological Formulation of Triacetyloleandomycin Hard Gelatin
Capsules; Bull. Fac. Pharm., Cairo University, Vol. XI, No. 1, 233
(1972).
6. Technological Formulation of Triacetyloleandomycin Oral Suspension;
Bull Fac. Pharm., Cairo University, Vol. XI, No. 1, 303 (1972).
7. Formulation of L-Chloramphenicol Hard Gelatin Capsules; Bull. Fac.
Pharm., Cairo University, Vol. XI, No. 2, 221 (1972).
8. Formulation of Chewable L-Ascorbic Acid Tablets; Bull. Fac. Pharm.,
Cairo University, Vol. XII, No. 1, 1 (1973).
9. Spermicidal Activity of Phenylmercuric Nitrate With and Without
Other Spermicides in Ointments Using Human Sperms; Bull. Fac.
Pharm., Cairo University, Vol. XII, No. 2, 25 (1973).
10.Physical Parameters and Release of Antazoline Hydrochloride
Suppositories as a Function of Particle Size, Concentration and
Nature of the Base; Proc. XII Conf. Pharm. Sci., Cairo, Egypt, 187
(Feb. 1974).
11.Formulation of Some Contraceptive Pessaries; Bull. Fac. Pharm.,
Cairo University, Vol. XII, No. 1, 67 (1974).
12.Release and Antimicrobial Properties of Iodine in Certain
Pharmaceutical Gels; Bull. Fac. Pharm., Cairo University, Vol. XIII,
No. 1, 77 (1974).
13.Effect of Certain Hydrocolloids on the Stability of Liquid Paraffin
Emulsion; Bull. Fac. Pharm., Cairo University, Vol. XIII, No. 1, 23
(1974).
14.In-Vitro Release of Noramidopyrine Methansulfonate as a Function of
Partiele Size and Concentration; Die Pharmazie, 30, H, 7, 475 (1975).
4
15.In-Vitro Release of Chloramphenicol from Different Suppository
Bases; Die Pharmazie, 30, H. 7, 472 (1975).
16.Evalution of Certain Spermicidal Formulations; Bull. Fac. Pharm.,
Cairo University, Vol. XIV, No. 1, 155 (1975).
17.Spermicidal Activity of Quinine Bisulphate With and Without Other
Spermicides in Ointments Using Human Sperms; Bull. Fac. Pharm.,
Cairo University, Vol. XIV, No. 2, 199 (1975).
18.Formulaion and Bioavailability of Trisulphonamide Suspension; Bull.
Fac. Pharm., Cairo University, Vol. XIV, No. 1,55 (1975).
19.Physicochemical
Stability
and
Bioavailability
of
Antazoline
Hydrochloride Suppositories; Bull. Fac. Pharm., Cairo University,
Vol. XIV, No. 2, 239 (1975).
20.Stability of Hydrogen Peroxide in Certain Pharmaceutical Gels; J.
Cosmetics and Toiletries,91, 54 (1976).
21.Formulation and Stabilization of Antazoline Hydrochloride Nasal
Drops; Bull. Fac. Pharm., Cairo University, Vol. XV, No. 1, 161
(1976).
22.Formulation of Vaginal Contraceptive Foaming Tablets; Bull. Fac.
Pharm., Cairo University, Vol. XV, No. 1, 81 (1976).
23.Reliability, Safety and Stability of Vaginal Contraceptive Foaming
Tablets Containing Parabens Mixture; Bull. Fac. Pharm., Cairo
University, Vol. XV, No. 1, 107 (1976).
24.Formulation of Phenylbutazone Tablets; Bull Fac. Pharm., Cairo
University, Vol. XV, No. 1, 193 (1976).
25.Formulation of Phenylbutazone Suspension; Bull. Fac. Pharm., Cairo
University, Vol. XV, No. 1, 177 (1976).
5
26.Effect of Vehicles on the Spermicidal Potency of Certain Drugs; Die
Pharmazie, 32, H. 7, 403 (1977).
27.Physical Parameters of Chlorpheniramine Maleate Suppositories and
its Release as a Function of Particle Size, Concentration, and Nature
of the Base; Die Pharmazie, 32, H. 8/9, 515 (1977).
28.Formulation and Stabilization of Nystatin Pessaries; Bull. Fac. Pharm.,
Cairo University, Vol. XVI, No. 1, 1 (1977).
29.Formulation and Stabilization of Furazolidone Pessaries; Bull. Fac.
Pharm., Cairo University, Vol. XVI, No. 1, 37 (1977).
30.In-Vitro and In-Vivo Evaluation of Chloramphenicol from Acrylic
Resin Coprecipitates; Bull. Fac. Pharm., Cairo University, Vol. XVII,
No. 1, 17 (1978).
31.Effect of Certain Additives on the Rheological Characteristics of Auby
Gum X Mucilage; Bull. Fac. Pharm., Cairo University, Vol. XVII,
No. 1, 29 (1978).
32.Kinetics of Paracetamol Release from Suppositories; Bull. Fac.
Pharm., Cairo University, Vol. XVII, No. 1, 1 (1978).
33.Availability of Norethisterone from Combined Oral Contraceptive
Tablets; Die Pharmazie, H. 1, 49 (1979).
34.Rectal Absorption Profile of Chloramphenicol in Dogs; Pharm. Ind.,
41, 1, 91 (1979).
35.Correlation Between the Spermicidal Activity and the Haemolytic
Index of Certain Plant Saponins; Die Pharmazie, 34, H. 9, 560 (1979).
36.Release
Characteristics
of
Phenylbutazone
From
Different
Suppository Bases; Bull. Fac. Pharm., Cairo University, Vol. XVIII,
No. 2, 155 (1979).
6
37.Characteristics of Oxyphenbutazone Release From Suppositories; Die
Pharmazie, 35, H. 3, 171 (1980).
38.Availability of Oxyphenbutazone From Different Suppository Bases;
Die Pharmazie, 35, H. 4, 213 (1980).
39.Formulation of Rapidly Disintegrable Vaginal tablets; Bull. Fac.
Pharm., Cairo University, Vol. XIX, No. 1, 243 (1980).
40.Effect of Different Plasticizers on the Release of Chloramphenicol
From its Microcapsules; Bull. Fac. Pharm., Cairo University, Vol.
XX, No. 1, 107 (1981).
41.Investigation
of
the
Discoloration
Developed
in
Aged
Chloramphenicol Suppositories; Die Pharmazie, 36, H. 6, 362 (1981).
42.Pharmacokinetics of Serum Albumin Binding and Release of Certain
sulfonylureas; Pharm. Ind., 7, 681 (1981).
43.Interaction of Carbopol 934 with Certain Antihistaminic Drugs; Die
Pharmazie, 36, H. 5, 356 (1981).
44.Binding of Xanthine Derivative to Human Serum Albumin as a
Function of pH; Acta Pharm. Suec., 18, 379 (1981).
45.Effect of HLB, Concentration and Nature of Surfactant on the Release
of Salicylates From Oleagenous Suppository Base; Canad. J. Pharm.
Sci., 16, 49 (1981).
46.Reactivity of Various Antacids as a Function of Adsorption of Certain
Antihistaminic Drugs; Bull. Fac. Pharm., Cairo University, Vol. XX,
No. 1, 185 (1981).
47.A new Concept for Oxyphenbutazone Gel Formulation Using
Methacrylate and Carboxy Vinyl Polymers; Pharm. Ind., 44, 12, 1284
(1982).
7
48.Effect of Albumin Conformation on the Binding of Phenylbutazone
and Oxyphenbutazone to Human Serum; J. Pharm. Sci., 71, 2, 241
(1982).
49.Standards For a Good Toothpaste; Bull. Fac. Pharm., Cairo
University, Vol. XXI, No. 1, 217 (1982).
50.In-Vitro Release of Paracetamol From Different Suppository Bases;
Pharm. Ind., 45, 1, 87 (1983).
51.Rectal Absorption Profile of Paracetamol From Different Suppository
Bases; Pharm. Ind., 45, 3, 307 (1983).
52.Interaction of Mefenamic Acid With Certain Human Plasma Proteins
and Their Substitutes; 43 rd International Congress of Pharmaceutical
Science, Montreux 5-9 Sep. (1983).
53.Dissolution Rate of Chloramphenicol From Hard Gelatin Capsules as
a Function of Type of Adjuvants and Method of Granulation; Die
Pharmazie, 39, H. 2, 110 (1984).
54.Efficacy of Different Emulsifying Agents in Preparing O/W/O or
W/O/W Multiple Emulsions; Pharm. Ind., 46, 964 (1984).
55.Effect of Certain Binders on the Physical and Rheologicl
Characteristics of Calcium Carbonate Toothpastes; XVII Conf. of
Pharm. Sci. Held In Cairo in 23-26 Feb. (1982).
56.Rheological Properties of Certain Binder Solutions as a Function of
Other Toothpaste Ingredients; Egypt, J. Pharm. Sci., 26, No. 1-4, 225
(1985).
57.Factors Affecting Drug Release From Different Polymeric Films; Bull.
Fac. Pharm., Ciro University, Vol. XXIV, No. 1, 157 (1985).
58.Interaction of Trimethoprim With Human Serum Albumin; Egypt. J.
Pharm. Sci., 27, No. 1-4, 113 (1986).
8
59.Interaction of Chlorpheniramine Maleate With Carrageenan; Egypt. J.
Pharm. Sci., 27, No. 1-4, 103 (1986).
60.Binding of Ibuprofen to Human Serum Albumin as a Function of pH,
Serum Albumin and Heavy Metal Ions; First Int. Conf. App. Sci.,
Vol. 1, (1986).
61.Formulation of Liquid Controlled - Release Dosage Forms of
Chlorpheniramine Maleate, I ; Ion Exchange Resin System.
Proceedings of 4 th International Conference on Pharmaceutical
Technology, 79 June 1986.
62.Formulation of Liquid Controlled - Release Dosage Forms of
Chlorpheniramine Maleate, II ; Multiple Emulsions. Proceedings of
4th Interational Conference on Pharmaceutical Technology. 299 June
1986.
63.A
pharmaceutical
Chlorpheniramine
Study
Maleate;
on
the
Micro-Encapsulation
Proceedings
of
4th
of
International
Conference on Pharmaceutical Technology, 245 June 1986.
64.Kinetics of Glucose and Yield of Multiple Emulsions as a Function of
Different Formulation Factors; Egypt. J. Pharm. Sci. 28, No. 1-4, 327
(1987).
65.Binding of Certain Anti-Inflammatory Drugs to Plasma Protein of
Diabetic Patients; Bull. Fac. Pharm. Cairo University, Vol. XXVI,
No. 1, (1987).
66.Certain Binding Characteristics of Azapropazone to Human Serum
Albumin; Bull. Fac. Pharm., Cairo University, Vol. XXVI, No. 1,
(1987).
67.Development and Application of a Spectrophotometric Method for the
Quantitation of Metoclopropamide in Urine; Egypt. J. Pharm. Sci.,
29, No. 1-4, 493 (1988).
9
68.Pharmacokintics of Salicylate in Bilharzial Patients; Egypt. J. Bilh.,
10, No. 1, 61 (1988).
69.Microencapsulation
of
Mebeverine
Hydrochloride
Resinates;
Proceeding of XXI Conf. of Pharm. Sci., 20 Feb. (1989).
70.Physical Stability and Rheological Properties of W/O/W Emulsions as
a Function of Electrolytes; Pharm. Ind., 52, 3, 357 (1990).
71.Controlled Crystallization of Chloropropamide From Surfactant and
Polymer Solution; Drug Develop. Ind. Pharm. (1990).
72.In-Vitro and In-Vivo Release of Meclazine Hydrochloride From its
Suppositories; Bull. Fac. Pharm., Cairo University, Vol. 29, No. 1,
(1991).
73.A Bioequivalence Studdy on Piroxicam from Different Capsule
Brands; Proceedings of XXII Conference of Pharmaceutical Sciences,
Egypt, 1, 1991.
74.Interaction of Sulfamethoxazole With Human Serum Albumin as a
Function of pH and Buffer Ion Composition; Egypt. J. Med. Sci. (In
Press).
75.Interaction of Indomethacin With Certain Human Plasma Proteins and
Their Substitutes; Egypt. J. Pharm. Sci. (In Press).
76.Bioavailability of Glibenclamide; Bull. Fac. Pharm. Cairo University.
(In Press).
77.Correlation of In-Vitro and In-Vivo Availability of Indomethacin
From Different Dosage Forms; Proceedings of 22 nd Conference of
Pharmaceutical Sciences, Egypt, 30, 1991.
78.In-Vitro In-Vivo Correlation of Paracetamol Availability From
Suppositories as a Function of the Technique used; Proceedings of 22
nd Conference of Pharmaceutical Sciences, Cairo, Egypt, 55, 1991.
10
79.In-Vitro and In-Vivo Availability of Paracetamol From Different
Commercial Tablets in Egypt; Bull. Fac. Pharm. Cairo University, 29,
3, 27, 1991.
80.Formulation and Bioavailability of Rifampicin Suspension; Egypt. J.
Pharm. Sci., 33, 997, 1992.
81.Formulation and Bioavailability of Rifampicin Capsule; Egypt. J.
Pharm. Sci., 33, 1013, 1992.
82.Temperature Cycling for Prediction of Aging of Toothpastes; Bull.
Fac. Pharm. Cairo University, 31, 2, 255, 1993.
83.Biopharmaceutical Evaluation of Tenoxicam Suppositiories; Bull. Fac.
Pharm. Cairo Univ., Vol. 33 No. 1, 51, 1995.
84.Formulation and Evaluation of Tenoxicam Capsules; Bull. Fac.
Pharm. Cairo Univ., Vol. 33 No. 1, 59, 1995.
85.Dissolution Performance and Relevant In-Vivo Studies of Piroxicam
Capsules; Bull. Fac. Pharm. Cairo Univ., Vol. 33 Special Issue, 75,
1995.
86.Effect of Gamma-Radiation on the Sn (II) Content Radiochemical
Purity, In-Vitro Stability and Biological Distribution of Some 99m
Tc-Labelled Freeze Dried Kits: Journal of Radioanalytical and
Nuclear Chemistry, Articles, Vol. 196, No.1 45-55 (1995).
87.The Application of Experimental Designs in Studying The
Availability of Griseofulvin From Tablet Dosage Forms.
Bull. Fac. Pharm. Cairo Univ., Vol 34.No.2. 161, (1996)
88.Agreement Between Pooled Sample Technique and Trapezoidal Rule
in Determining the Bioequivalence of Certain Metronidazole Tablets:
Bull. Fac. pharm. Cairo Univ., 34 (3) 203, 1996.
11
89.Effect of Chemical Structure on the Release of Certain Propionic Acid
Derivatives from Their Dosage Forms.
Bull. Drug Development and Industrial Pharmacy, 24 (5), 1-7 (1998).
90.Preparation and Evaluation of Freeze-Dried MAG3 Kits for 99mTcLabelling.
91.Organic Synthesis and Direct Labelling of Benzoyl Protected
Mercaptoacetyltriglycine (S-BZ-MAG3) with Technetium - 99m as
Tubular Function Agent.
92. In Vitro and In Vivo Evaluation of Formulated Lidocaine Dental Gels
and Ointments.
Egypt. J. Pharm. Sci 38, No 4-6, 471-486 (1997).
93. Formulation of Meloxicam Suppositories.
AZ. J. Pharm. Sci, Vol. 23, (1999).
94. Polymorphic Transformation of Losartan.
Egypt J. Pharm. Sci., 40, (1), 49-59 (1999).
95. Formulation and Evaluation of Controlled Release Ketoprofen
Granules Prepared by Pan Coating Method.
Bull. Fac. Pharm. Cairo Univ. 38 (3) 197-208 (2000).
96. Formulation and Evaluation of Controlled Release Ketoprofen
Coprecipitat.
Bull. Fac. Pharm. Cairo Univ. 38 (3) 209-218 (2000).
97. Reversed Phase Liquid Chromatographic Determination of
Meloxicam in Human Plasma and its Pharmacokinetic Application.
J. Analytical Letters 34 (7) 1175 – (2001).
98. Formulation and Evaluation of Controlled Release Ibuprofen
Granules and Coprecipitat.
12
Accepted in Bull. Fac. Pharm. Cairo Univ. in (13 - 12 - 2000).
99. Preparation and Pharmacokinetic Evaluation of Carbamazepine
Controlled Release Solid Dispersion Granules
J. Drug Res. Egypt, 22, 15 (1998)
100. Formulation, Evaluation and Bioequivalence Study
of
Carbamazepine Tablets Via Solid Dispersion of the Drug.
Egypt J. Pharm. Sci., 39, 307 (1998).
101. High-performance Liquid Chromatographic Determination of
Neutraceuticals, Glucosamine Sulphate and Chitosan, in Raw
Materials and Dosage Forms
Analytical Chemica Acta 462 (2002) 125-131
102. Reversed Phase Liquid Chromatographic Determination of
Vinpocetine in Human Plasma and its Pharmacokinetic Application
Analytical Letters, 35(6), 1041-1054 (2002)
103. Improving the Dissolution and Bioavailability of Nifedipine Using
Solid Dispersions and Solubilizers
Drug Development and Industrial Pharmacy Vol. 28, No. 7, pp. 795807, 2002
104. Reversed Phase Liquid Chromatographic Determination of
Nimesulide in Human Plasma and its Pharmacokinetic Application
Kasr El-Aini Medical Journal Vol., 8, No, 4, July Sup. 2002.
105. Enhancement of carbamazepine dissolution: in vitro and in vivo
evaluation : International journal of pharmaceutics 168 (1998) 209220.
106. Lactic acid-induced modifications in films of Eudragit RL and RS
aqueous dispersions: International Journal of Pharmaceutics 274
(2004) 85-96.
13
107. Stability indicating high performance liquid chromatographic assay
for the determination of sildenafil citrate in bulk and in
formulations: Chromatographia 59, 561 (No. 9/10) 2004.
108. Preformulation compatibility study of amlodipine besylate with
commonly used tablet and capsule excipients : Egyptian Journal of
Biomedical Sciences vol. 15, 2004.
109. A stability study of Rifampicin : Bull. Fac. Pharm. Cairo Univ., Vol.
42, No. 2 (2004).
110. A stability indicating high performance liquid chromatographic
assay for the determination of ampicillin in bulk and in capsules:
Bull. Fac. Pharm. Cairo Univ., Vol. 42, No. 2 (2004).
111. Study on the drug interactions encountered in prescriptions
commonly written in clinical practice: The New Egyptian Journal of
Medicine, Vol. 31, No. 4 (2004).
112. Nanosuspension as an ophthalmic delivery system for certain
glucocorticoid drugs: International Journal of Pharmaceutics, 340,
126-133(2007).
113. Ahmed Abd Elbary, Hanan.M.El-laithy, and Mina I.Tadros
Promising ternary dry powder inhaler formulations of cromolyn
sodium: Formulation and in vitro-in vivo evaluation, Arch pharm
res, vol. 30, no.6, 785-792(2007)) .
114. Formulation and Evaluation of Ciprofloxacin Hydrochloride Eye
drops. Egypt. J. Biomed. Sci. 19, 37-57 (2005).
115. Liquid Chromatographic Determination of Zaleplon in Human
Plasma and its Pharmacokinetic Application. Anal. Letters, 39 (9),
1891-1905 (2006).
116. A.Abd-Elbary, H.M.El-laithy *, M.I. Tadros, Sucrose stearatebased proniosome-derived niosomes for the nebulisable delivery of
cromolyn sodium International Journal of Pharmaceutics
357(2008)189-198.
117. Ahmed Abd Elbary1, Mahfouz A. Kassem2, Mona M. Samra2,
Rawia M. Khalil2* Formulation and hypoglycemic activity of
pioglitazone-cyclodextrin inclusion complexes. Drug Discov ther
2008; 2(2):94-107.
14
118.
Nagwa H . Foda ,O. Naeem , A . Abd ELbary and G. Abd
ELbary.
Simultaneous HPLC determination of Enalapril and
Hydrochlorothiazide in Human Plasma and its pharmacokinetic
application. J. Pharm. Sci. & Res. Vol.2 (11), 2010,786-794
119.
Ahmed Abdelbary, Omaima N. El-Gazayerly, Nashwa A. ElGendy and Adel A. Ali. Floating Tablet of Trimetazidine
Dihydrochloride: An Approach for Extended Release with ZeroOrder Kinetics. AAPS PharmSciTech. Volume 11, Number 3,
2010, 1058-1067
120.
A Abdelbary, Omneya M Khowessah and Mugahed M. AlGamrah. Formulation and Evaluation of Amlodidpine Besylate
Fast Dissolving Tablets. Inventi Rapid: Pharm Tech. Vol.1, Issue
1, 2010.
121.
Abdelbary
AA,
Salem
HF
and
Kharshoum
RM.
2-
Hydroxypropyl-β-Cyclodextrrin Complex with Ketotifen Fumarate
for Eye Drops Preparations. International Journal of Drug
Delivery. Vol 3, 2011, 228-240.
122.
A.A. Abdelbary, H.F. Salem and M.E. Maher. In vitro and in vivo
Evaluation of Glibenclamide using Surface Solid Dispersion (SSD)
Approach. British journal of Pharmacology and Toxicology. Vol. 2
(1), 2011, 51-62.
123.
Mohammed Shafik El-Ridy, Ahmed Abdelbary, Tamer Essam,
Rania Mohsen Abd El-Salam and Ahmed Aly Kassem. Niosomes
as potential drug delivery systems for increasing the efficacy and
safty of nystatin. Drug Development and Industrial Pharmacy.
2011, 1-18.
124.
M. A. Motaleb, M. T. El-Kolaly, H. M. Rashed and A. Abd ElBary. Novel radioionated sibtramine and fluxetine as models for
brain imaging. J Radioanal Nucl Chem. 2011.
15
125.
A. Abdel-Bari, M. Sherif Mokhtar, Nagwa Ali Sabry, Sanaa Abd
El-Shafi and Naglaa Samir Bazan. Once versus individualized
multiple daily dosing of aminoglycosides in critically ill patients.
Pharmaceutical Saudi Journal. Vol. 19 (1), 2011, 9-17.
126.
Ahmed A. Elbary, Afaf A. Ramadan, Ehab R. Bendas and Dalia
Abd Elatty Mostafa. Formulation and Evaluation of Taste Masked
Rapidly
Disintegrating
Tablet
Containing
Flupentixol
Dihydrochloride. International Research Journal of Pharmacy.
2011.
127.
Ahmed Abd-Elbary, Mina Ibrahim Tadros and Ahmed Adel
Alaa-Eldin. Development and In Vitro/ In Vivo Evaluation of
Etodolac Controlled Porosity Osmotic Pump Tablets. AAPS
PharmSciTech, Vol.12, No. 2, 2011, 485-495.
128.
A. Abdelbary, M. Haider and S. Sayed. In vitro Characterization
and release study of Ambroxol hydrochloride matrix tablets
prepared by direct compression. Pharmaceutical Development and
Technology.2011, 1-12.
16